We are live on ! Find out more
MBX

MBX Biosciences

Name Holding Trade Value Shares
Change
Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$44.2M
O
2
OrbiMed
New York
$29.5M +$2.02M +190,672 +5%
NMC
3
NEA Management Company
Maryland
$26.7M
DTC
4
Deep Track Capital
Connecticut
$22.3M
Wellington Management Group
5
Wellington Management Group
Massachusetts
$19.5M -$2.87M -271,118 -9%
NA
6
NVP Associates
California
$15.8M
DCM
7
Driehaus Capital Management
Illinois
$11.7M -$27K -2,553 -0.2%
RCM
8
RA Capital Management
Massachusetts
$11.2M
EC
9
EcoR1 Capital
California
$9.29M
MB
10
MPM BioImpact
Massachusetts
$8.36M +$12M +1,132,950 New
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$8.13M -$641K -60,611 -5%
WP
12
Woodline Partners
California
$6.48M +$2.84M +268,740 +44%
BlackRock
13
BlackRock
New York
$5.78M +$582K +55,090 +8%
CAM
14
Cormorant Asset Management
Massachusetts
$5.17M
Vanguard Group
15
Vanguard Group
Pennsylvania
$4.91M -$56.9K -5,385 -0.8%
TCM
16
TCG Crossover Management
California
$4.8M
Franklin Resources
17
Franklin Resources
California
$2.73M +$159 +15 +0%
PHP
18
Parkman Healthcare Partners
Connecticut
$2.42M +$1.67M +158,323 +93%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$2.03M +$92.6K +8,755 +3%
OM
20
Opaleye Management
Massachusetts
$1.84M +$2.64M +250,000 New
JP Morgan Chase
21
JP Morgan Chase
New York
$1.49M +$2.03M +192,129 +2,110%
SSA
22
Schonfeld Strategic Advisors
New York
$1.48M +$1.37M +129,142 +181%
PIM
23
Platinum Investment Management
Australia
$1.37M +$252K +23,842 +15%
State Street
24
State Street
Massachusetts
$1.31M +$366K +34,571 +24%
AAA
25
Affinity Asset Advisors
New York
$1.29M +$1.85M +175,000 New